510(k) K182387

NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector) by Novo Nordisk, Inc. — Product Code FMF

K182387 is an FDA 510(k) premarket notification submitted by Novo Nordisk, Inc. for the device "NovoPen Echo Dial-A-Dose Insulin Delivery Device (Pen Injector)". The FDA issued a decision of Substantially Equivalent on December 17, 2018. The device falls under product code FMF (Syringe, Piston), a Class II device regulated under 21 CFR 880.5860. Novo Nordisk, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 17, 2018
Date Received
September 4, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Syringe, Piston
Device Class
Class II
Regulation Number
880.5860
Review Panel
HO
Submission Type